The Marzetti Company <MZTI.O>: Jefferies cuts target price to $118 from $125
MZTI•Related News
GitLab Inc. <GTLB.O>: JP Morgan Raises Target Price to $44 From $32
GTLB•
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared To Durvalumab Plus Chemotherapy In First-Line Advanced Biliary Tract Cancer In Single-Region Trial Conducted By Akeso In China
SMMT•
Zymeworks Inc. <ZYME.O>: Jefferies raises target price to $50 from $43
ZYME•
Intuit Inc. <INTU.O>: Barclays cuts target price to $408 from $443
INTU•
Copper firms on worries over dwindling LME inventories
COPX•